VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $9,000 | -95.6% | 350 | -77.6% | 0.00% | -83.3% |
Q3 2014 | $205,000 | +37.6% | 1,560 | +32.2% | 0.01% | +71.4% |
Q2 2014 | $149,000 | -60.5% | 1,180 | -58.7% | 0.01% | -30.0% |
Q1 2014 | $377,000 | -2.1% | 2,860 | -12.7% | 0.01% | +42.9% |
Q4 2013 | $385,000 | +14.9% | 3,276 | +2.1% | 0.01% | +16.7% |
Q3 2013 | $335,000 | +313.6% | 3,210 | +241.5% | 0.01% | +500.0% |
Q2 2013 | $81,000 | – | 940 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |